AJP Legacy  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 194: 1-6, 1958;
0002-9513/58 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, B. R.
Right arrow Articles by Jensen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, B. R.
Right arrow Articles by Jensen, H.

Role of Plasma Accelerator-Globulin and Serum Accelerator-Globulin in Conversion of Prothrombin

Betty R. Johnston 1 and H. Jensen 1

1 From the Biochemistry Department, U. S. Army Medical Research Laboratory, Fort Knox, Kentucky

Either plasma accelerator-globulin or serum accelerator-globulin must be present in order to obtain complete conversion of prothrombin in the presence of serum-eluate factor(s) [proconvertin or plasma thromboplastin component or both], antihemophilic factor, platelet factor 3, and calcium ions. If plasma accelerator-globulin is present, it must first be converted to serum accelerator-globulin by the action of thrombin before the maximum rate of prothrombin conversion is reached. Serum accelerator-globulin does neither affect the degree nor the rate of interaction of serum-eluate factor(s), antihemophilic factor, platelet factor 3, and calcium ions forming a prothrombin-conversion factor but affects thrombin formation at a point just prior to or during the conversion of prothrombin.

Submitted on December 15, 1957







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1958 by the American Physiological Society.